Meridian Labs patents expiration
1. Docetaxel patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10398785 | MERIDIAN LABS | Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use |
Mar, 2036
(12 years from now) | |
Drugs and Companies using DOCETAXEL ingredient
Market Authorisation Date: 22 November, 2022
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
DOCETAXEL family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic